– Acquired Significantly Below Replacement Cost –– Property Provides Long-Term Repositioning Opportunity –– 2026 Year-to-Date Investments Total $334 Million – WINTER PARK, Fla., Sept. 14, 2026 (GLOBE NEWSWIRE) — CTO Realty Growth, Inc. (NYSE: CTO) (the “Company” or “CTO”) today announced the acquisition of Zona Rosa, a 768,000 square foot mixed-use center located in Kansas City, Missouri, for $63.3 million, or $82 per square foot. The Company believes the combination of strong market demographics combined with its proven expertise to extract meaningful value from prior repositioning executions will provide the opportunity to produce a compelling initial yield and long-term return. “With the addition of this new property, our year-to-date property acquisition volume now exceeds $200 million...

Acquisition positions Veracyte to deliver powerful genomic insights from urine, tissue, and blood to help guide bladder cancer care across the patient journey SOUTH SAN FRANCISCO, Calif., Sept. 14, 2026 (GLOBE NEWSWIRE) — Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced its acquisition of Convergent Genomics. The acquisition adds Convergent Genomics’ UroAmp platform, including its proprietary urinary tumor DNA (utDNA) technology, to Veracyte’s product portfolio. To date, UroAmp has been clinically validated in non-muscle invasive bladder cancer (NMIBC), including therapy-response monitoring and post-treatment surveillance. In the U.S., there are approximately 85,000 patients diagnosed with bladder cancer annually, including about 65,000 with NMIBC. Of the 750,000 patients living with bladder cancer,...

THE DISSEMINATION, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IS NOT AUTHORIZED IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER COUNTRY WHERE SUCH COMMUNICATION WOULD VIOLATE APPLICABLE REGULATIONS Ivry-sur-Seine – France, September 14, 2026, 5:45 PM CET FILING WITH THE EUROPEAN COMMISSION OFTHE TAKEOVER BID INITIATED BY EP GROUP FOR MERGER CONTROL PURPOSESFiling by EP FR HOLDCO of the formal notification with the European Commission Merger control clearance expected by early November Closing of the Offer expected by the end of 2026EP FR HOLDCO, a company controlled by EP Group and set up for the purposes of the Offer, announced that it has today filed with the European Commission the formal notification under merger control of its proposed public tender offer...

Wellthy’s acquisition of Cleo brings together two leaders in family care, expanding support for employers, health plans, and families. NEW YORK, Sept. 14, 2026 (GLOBE NEWSWIRE) — Wellthy today announced its acquisition of Cleo, bringing together two leaders in family care around a shared vision: creating the singular platform for family care. Together, Wellthy and Cleo will combine deep human expertise, intelligent technology, and complementary capabilities to help employers, health plans, and families across the full continuum of need—from the everyday moments of growing and caring for a family to some of life’s most complex health and caregiving challenges around the globe. Family care rarely follows a straight line. Needs evolve, overlap, and often span generations at once. A new parent may also be caring for an aging parent....

On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. As outlined in Company Announcement no. 48 of 14 August 2026, the programme was extended with up to DKK 170 million, increasing the total amount of which Schouw & Co. will acquire shares to up to DKK 410 million. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price Amount DKK    Accumulated until 4 September 2026 370,083 680.43 251,814,550    Monday,...

Previously disclosed non-binding LOIs contemplate approximately $240 million in aggregate implied property value across two South Florida multifamily properties totaling approximately 544 units FORT LAUDERDALE, Fla., Sept. 14, 2026 (GLOBE NEWSWIRE) — Stewards, Inc. (Nasdaq: SWRD) (“Stewards” or the “Company”), a diversified financial platform spanning private credit, real assets and technology, today provided an update regarding its previously disclosed non-binding letters of intent (“LOIs”) for the proposed acquisitions of PIXL at Plantation and Envy Pompano Beach, two South Florida multifamily properties comprising approximately 330 and 214 units, respectively. The Company previously disclosed the LOIs in its Quarterly Report on Form 10-Q for the quarter ending June 30, 2026. Under the terms contemplated by the LOI, Stewards would...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree APTITUDE SOFTWARE GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: APTITUDE...

TORONTO and PERTH, Western Australia, Sept. 14, 2026 (GLOBE NEWSWIRE) — Cygnus Metals Limited (ASX: CY5; TSXV: CYG; OTCQB: CYGGF) (“Cygnus” or the “Company”) refers to the proposed transaction under which Central Asia Metals PLC (AIM: CAML) (“CAML”) will acquire 100% of the shares in Cygnus pursuant to a scheme of arrangement under Part 5.1 of the Corporations Act 2001 (Cth) (“Scheme”). Capitalised terms in this announcement that are not otherwise defined have the meanings given to them in the Scheme Booklet dated 13 August 2026 (“Scheme Booklet”). Scheme Meeting reminder As outlined in the Scheme Booklet, the Cygnus shareholder meeting to approve the Scheme (“Scheme Meeting”) is scheduled to take place at the offices of Hamilton Locke at Level 39, 152-158 St Georges Terrace, Perth WA 6000 at 2.00pm (AWST) on 18 September 2026....

Media RelationsSam ConnattyTel.: +44 (0) 7811 486517E-Mail: sam.connatty@capgemini.com Investor Relations:Vincent BiraudTel.: +33 1 47 54 50 87E-mail: vincent.biraud@capgemini.com Capgemini signs a definitive agreement to sell Capgemini Government Solutions Paris, September 12, 2026 – Capgemini today announces that it has entered into an agreement with ITC Federal, a US IT solutions and enterprise services provider to federal law enforcement, homeland security and defense agencies, for the sale of Capgemini Government Solutions, its subsidiary working with the US federal government. This transaction is expected to close in the coming weeks, subject to customary conditions for a transaction of this nature. As indicated when the Group announced the launch of the divestment process earlier this year, Capgemini Government Solutions represented...

HOUSTON, Sept. 11, 2026 (GLOBE NEWSWIRE) — Impact BioMedical Inc. (the “Company”) today announced that the Company’s Board of Directors has approved a 1 for 12.62 reverse stock split of the Company’s issued and outstanding common stock, par value $0.001 per share (the “Common Stock“). The reverse stock split will become effective at 12:01 a.m., Eastern Time, on September 23, 2026. Starting with the opening of trading on that date, the Company’s Common Stock will continue to trade on the NYSE American Exchange under the ticker symbol “IBO” and will trade under a new CUSIP number to be assigned in connection with the reverse stock split. On December 30, 2025, the Company’s stockholders approved a second reverse stock split of the Company’s Common Stock at a ratio of not less than 1-for-12.48 and...